Adherence to Monitoring Guidelines of Amiodarone Adverse Reactions.

Health Serv Res Manag Epidemiol

Clinical Pharmacology and Toxicology Unit, Carmel Medical Center, Haifa, Israel.

Published: April 2019

Background: Amiodarone treatment frequently causes adverse reactions. Clinical guidelines warrant a comprehensive assessment prior to chronic treatment with amiodarone and repeated monitoring for the appearance of adverse reactions.

Objective: To evaluate adherence to these guidelines.

Methods: A retrospective chart review of electronic medical records of adult patients treated with oral amiodarone for at least 12 months.

Results: One hundred patient records were analyzed; 97% of patients were evaluated for thyroid and liver functions prior to treatment. Liver functions were properly monitored every 6 months in 96% of patients and thyroid function in only 59%. Most (84%) patients completed a chest X-ray before treatment; only 2% completed a respiratory function test. None have performed a chest X-ray annually. Sixty-four percent of the patients were examined by an ophthalmologist prior to treatment; periodic ophthalmic surveillance was not consistent. Neurological and dermatological evaluations were not recorded for any of the patients, unless symptoms appeared. Only 50% were adherent to annual cardiac reassessment.

Conclusions: Adherence to recommended clinical guidelines for monitoring amiodarone adverse reactions is poor. Interventions to improve compliance with these guidelines are needed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472159PMC
http://dx.doi.org/10.1177/2333392819844635DOI Listing

Publication Analysis

Top Keywords

adverse reactions
12
amiodarone adverse
8
clinical guidelines
8
liver functions
8
prior treatment
8
chest x-ray
8
patients
6
amiodarone
5
treatment
5
adherence monitoring
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!